ABT

Abbott Laboratories

102.45

Oct 20 • 3:59 PM ET -1.61 (-1.55%)

102.27

Aftermarket • 7:32 PM ET -0.18 (-0.18%)

Healthcare Medical Devices USA Large NYSE

Today, 2:05 AMAbbott's Cologuard Plus colorectal cancer stool DNA test receives CE Mark certification under EU IVDR

Peers: MDT BSX DXCM EW JNJ SYK DHR BDX MMED BAX

| Held by: VTI VOO SCHD IVV SPY VTV XLV VIG VYM IHI

Scroll to Statements

Index	S&P 500
Market Cap	177.28B
Enterprise Value	204.93B
Income	5.41B
Sales	46.59B
Book/sh	29.54
Cash/sh	3.24
Dividend Est.	2.58 (2.52%)
Dividend TTM	2.52 (2.46%)
Dividend Ex-Date	Oct 15, 2026
Dividend Gr. 3/5Y	7.72% 9.42%
Payout	64.54%
Employees	115000
IPO	Mar 01, 1937

P/E	33.11
Forward P/E	16.89
PEG	1.81
P/S	3.81
P/B	3.47
P/C	31.64
P/FCF	22.66
EV/EBITDA	18.45
EV/Sales	4.40
Quick Ratio	0.97
Current Ratio	1.38
Debt/Eq	0.64
LT Debt/Eq	0.58
Option/Short	Yes / Yes

EPS (ttm)	3.09
EPS next Y	6.06
EPS next Q	1.42
EPS this Y	7.13%
EPS next Y	9.91%
EPS next 5Y	9.33%
EPS past 3/5Y	-1.70% 8.23%
Sales past 3/5Y	0.51% 5.08%
EPS Y/Y TTM	-61.33%
Sales Y/Y TTM	8.06%
EPS Q/Q	-48.22%
Sales Q/Q	13.02%
Earnings	Oct 21 BMO
EPS/Sales Surpr.	2.56% 0.59%

Insider Own	0.68%
Insider Trans	-3.21%
Inst Own	82.19%
Inst Trans	-1.36%
ROA	5.59%
ROE	10.63%
ROIC	6.70%
Gross Margin	52.81%
Oper. Margin	16.44%
Profit Margin	11.60%
SMA20	1.47%
SMA50	-3.05%
SMA200	-0.14%
Trades

Shs Outstand	1.73B
Shs Float	1.72B
Short Float	0.79%
Short Ratio	1.54
Short Interest	13.63M
52W High	132.02 -22.40%
52W Low	81.97 24.98%
Volatility	1.87% 2.11%
ATR (14)	2.45
RSI (14)	49.90
Beta	0.55
Rel Volume	1.56
Avg Volume	8.88M
Volume	13,850,889

Perf Week	-0.16%
Perf Month	-0.51%
Perf Quarter	1.87%
Perf Half Y	10.49%
Perf YTD	-18.23%
Perf Year	-20.89%
Perf 3Y	5.86%
Perf 5Y	-16.92%
Perf 10Y	151.47%
Recom	1.55
Target Price	121.20
Prev Close	104.06
Price	102.45
Change %	-1.55%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-07-26	Initiated	Barclays	Overweight	$120
Oct-02-26	Upgrade	Rothschild & Co Redburn	Neutral → Buy	$127
Aug-13-26	Upgrade	Wolfe Research	Peer Perform → Outperform	$130
Jul-01-26	Initiated	Robert W. Baird	Outperform	$121
Apr-22-26	Downgrade	Daiwa Securities	Outperform → Neutral	$92
Oct-10-25	Initiated	The Benchmark Company	Buy	$145
Jul-18-25	Upgrade	Jefferies	Hold → Buy	$145
Jun-16-25	Initiated	Leerink Partners	Market Perform	$143
Oct-08-24	Initiated	Oppenheimer	Outperform	$130
Sep-19-24	Initiated	Piper Sandler	Overweight	$131
Jul-30-24	Downgrade	Edward Jones	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$121
Jul-21-23	Upgrade	Wolfe Research	Underperform → Peer Perform
May-30-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$112
Apr-20-23	Reiterated	Wolfe Research	Underperform	$107 → $103
Apr-20-23	Reiterated	UBS	Buy	$117 → $130
Apr-20-23	Reiterated	Raymond James	Outperform	$116 → $123
Apr-20-23	Reiterated	JP Morgan	Overweight	$118 → $122
Apr-20-23	Reiterated	Bernstein	Outperform	$132 → $133
Apr-20-23	Reiterated	Barclays	Overweight	$125 → $127

Show Previous Ratings

Today 02:00AM	Abbott's Cologuard Plus receives CE Mark for colorectal cancer screening in Europe (PR Newswire)
Oct-18-26 06:52PM	Tamboran Resources appoints Todd Abbott managing director as Beetaloo moves into development (Proactive)
Oct-16-26 07:29PM	Berkshire's Mind-Bender (Barrons.com)
Oct-15-26 05:01PM	Is Medtronic Stock A Buy Now That Sales Growth Has Picked Up? (Trefis)
03:18PM	Is Boston Scientific Stock Riskier Than It Was A Year Ago? (Trefis)
01:00PM	Loading…
01:00PM	The Week Ahead: Earnings Season Heats Up on Wall Street (Schaeffer's Research)
Oct-14-26 04:55PM	What Could BSX Stock Be Worth In Three Years? (Trefis)
Oct-13-26 08:20AM	Freenome Sinks 11% Despite Clinically Meaningful Gains for Next-Gen Colon Cancer Blood Test (TIKR)
Oct-12-26 02:07PM	Ascensia leads $36M funding round for glucose sensor startup (MedTech Dive)
01:16PM	Has Medtronic Stock Become A Different Bet? (Trefis)
Oct-08-26 09:41AM	Trump August disclosure: Meta stock, SpaceX debt purchases (Quartz)
03:40AM	Citi reiterates these 2 medtech stocks as its top picks in the sector (Investing.com)
Oct-07-26 09:00AM	Abbott introduces Ensure Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop (PR Newswire)
Oct-06-26 08:18AM	If The MiniMed Split-Off Stalls, What Happens To Your Medtronic Stock? (Trefis)
Oct-05-26 09:00AM	Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition (PR Newswire)
05:40PM	Loading…
Oct-02-26 05:40PM	How to Create a Million-Dollar Stock Portfolio (Zacks)
09:40AM	Nike downgraded, Airbnb upgraded: Wall Street's top analyst calls (The Fly)
Sep-30-26 10:58AM	Abbott launches Freenomes colorectal cancer screening test (MedTech Dive)
09:00AM	Abbott hosts conference call for third-quarter earnings (PR Newswire)
08:00AM	Abbott launches SimpleScreen CRC blood test, joining Cologuard Plus in its colorectal cancer screening portfolio (PR Newswire)
Sep-28-26 03:09PM	How Big Could BSX Stock's Next Fall Be? (Trefis)
Sep-23-26 07:23PM	FDA Advisors Said It Should Approve the Grail Multicancer Blood Test (Barrons.com)
07:00AM	Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health (PR Newswire)
Sep-22-26 09:29AM	How Far Can BSX Stock Swing After Losing More Than Half Its Value? (Trefis)
Sep-17-26 12:43PM	Abbott declares 411th consecutive quarterly dividend (PR Newswire)
12:31PM	Why BSX Stock Lost More Than Half Its Value While Sales Kept Rising (Trefis)
Sep-16-26 06:58AM	J&J sells Laminar LAA closure assets it bought 3 years ago (MedTech Dive)
Sep-15-26 03:00PM	Has BSX Stock Finally Hit Bottom? (Trefis)
Sep-14-26 02:01PM	Abbott agrees to settlement over closure of largest baby formula plant in the US (Associated Press)
11:52AM	Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall (PR Newswire)
02:50PM	Loading…
Sep-11-26 02:50PM	Is This BSX Stock Pullback Worth The Patience? (Trefis)
Sep-10-26 04:12PM	Top Research Reports for Goldman Sachs, RTX & Abbott (Zacks)
Sep-09-26 02:06PM	BSX Stock: Is It Time To Buy Or Sell Puts? (Trefis)
06:56AM	Abbotts dual ablation catheter lands FDA approval (Medical Device Network)
Sep-08-26 08:00AM	Abbott receives FDA approval for its TactiFlex Duo Ablation Catheter to treat people with abnormal heart rhythms (PR Newswire)
Sep-04-26 02:25PM	How Much Upside Can BSX Stock's Growth Deliver? (Trefis)
Sep-02-26 01:52PM	The Wide Divide Priced Into Boston Scientific Stock (Trefis)
Sep-01-26 04:48PM	Duncan Ferguson Joins Neovii Pharmaceuticals AG to Lead Global Commercial Expansion as Chief Commercial Officer (NewMediaWire)
09:20AM	Why Novartis Just Surged 6%, Eyeing A Breakout (Investor's Business Daily)
12:01AM	Abbott Introduces Americas First Liquid Baby Formula With Whole Milk (The Daily Upside)
Aug-31-26 08:47PM	The Peer-Group Mispricing Sitting On BSX Stock (Trefis)
04:23PM	How Abbott Labs Is Embracing RFK Jr.'s Make America Healthy Again Movement (Investor's Business Daily)
08:00AM	Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula (PR Newswire)
Aug-28-26 06:15AM	Abbott wins CE mark for new LAA closure device (MedTech Dive)
Aug-27-26 12:29PM	Has BSX Stock Fallen Far Enough To Buy? (Trefis)
09:00AM	Abbott's next-generation Amulet 360 device receives CE Mark to treat people with atrial fibrillation at risk of stroke (PR Newswire)
06:09AM	Dexcom, Abbott await Medicare coverage expansion for CGMs (MedTech Dive)
Aug-26-26 03:51PM	Time To Squeeze 14% Yield Out Of Battered BSX Stock? (Trefis)
06:48AM	Boston Scientific hit by cyberattack, global operations affected (Reuters)
Aug-25-26 03:30PM	Eli Lilly Is Pulling Away From the Rest of Healthcare (GuruFocus.com)
02:49PM	Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes (PR Newswire)
12:05PM	The Floor Under BSX Stock Is Being Tested Again (Trefis)
Aug-24-26 06:00AM	MiniMed starts shipping new insulin pump with Abbott-made sensor (MedTech Dive)
Aug-20-26 04:15PM	Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants (PR Newswire)
01:04PM	Amazon is bringing a multibillion-dollar robotics plant to Texas (USA TODAY)
Aug-17-26 01:45PM	Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare (PR Newswire)
Aug-14-26 06:00PM	Mason Hawkins's Key Second Quarter 2026 Move: A 3.98% Stake in Abbott Laboratories (GuruFocus.com)
05:54PM	Which Medtech Giant Would Buy Inspire Medical Systems? (Trefis)
Aug-13-26 05:21PM	How Much More Can Boston Scientific Stock Move After Losing Half Its Value? (Trefis)
08:37AM	Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle (Investing.com)
Aug-12-26 09:14AM	Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis (PR Newswire)
Aug-11-26 01:41PM	Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations (Proactive)
09:00AM	Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI (PR Newswire)
Aug-10-26 02:14PM	Boston Scientific Stock Is Priced As If WATCHMAN Were The Whole Company (Trefis)
Aug-07-26 09:00AM	Dont Want to Pay a Lot of Taxes? Move Your Company to This Tiny Mediterranean Archipelago. (Entrepreneur)
Jul-29-26 07:13AM	GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds (Reuters)
06:00AM	Abbott starts TriClip study amid rising competition for heart valve repair (MedTech Dive)
Jul-27-26 11:44AM	Leah Bennett: Where to Invest After the AI-Chip Stock Surge (Barrons.com)
11:37AM	Freenome secures FDA nod for blood-based colorectal cancer test (MedTech Dive)
Jul-24-26 08:25AM	6 Medical-Device Stocks to Buy After a Massive Selloff (Barrons.com)
08:23AM	Reading Between The Lines Of DHR's Latest Call (Trefis)
01:30AM	Medical-Device Stocks Are in the Bargain Bin. 6 to Buy. (Barrons.com)
Jul-21-26 02:55PM	Why BSX Stock Hands You So Much Cash Right Now (Trefis)
Jul-20-26 10:38AM	Tempus to buy cancer test-maker Personalis for $1.5B (MedTech Dive)
Jul-17-26 06:56PM	Abbott Just Showed Its Growth Engine Has More Than One Cylinder (Trefis)
08:17AM	Can Abbott Stock Deliver on Its Second-Half Growth Promise? (Trefis)
Jul-16-26 05:00PM	Abbott Laboratories (ABT) Q2 2026 Earnings Call Highlights: Strong Growth in Key Segments and ... (GuruFocus.com) +10.71%
12:23PM	Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlook (Proactive)
11:04AM	Healthcare sector is having a moment, driven by strong earnings reports (MarketWatch)
09:59AM	Why Abbott Stock Is Reimagining Its Future (Trefis)
09:19AM	Abbott Q2 2026 earnings beat, raises full-year profit guidance (Quartz)
09:01AM	Abbott Bounds Higher After Hiking 2026 Profit View On Second-Quarter Beat (Investor's Business Daily)
08:43AM	Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT) (InvestorsHub)
08:10AM	Abbott beats second-quarter estimates, raises 2026 guidance (Investing.com)
08:08AM	Abbott Laboratories Sales Rise on Diagnostics Growth (The Wall Street Journal)
08:05AM	Why Abbott Earnings Are Sending the Stock Higher (Barrons.com)
07:40AM	Abbott: Q2 Earnings Snapshot (Associated Press)
07:30AM	Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance (PR Newswire)
05:03AM	Netflix earnings on tap after rough period for the streaming company's stock (MarketWatch)
Jul-15-26 08:03AM	Abbotts cancer diagnostics vision: Theres always a hunger to make these tests better (MedTech Dive)
Jul-13-26 07:22AM	Freenome colorectal cancer test data improve on earlier results (MedTech Dive)
Jul-10-26 08:08AM	DXCM Grew. The Stock Did Not. Someone Is Wrong (Trefis)
Jul-09-26 09:40AM	The Wide Chasm Priced Into Boston Scientific Stock (Trefis)
Jul-08-26 05:38PM	Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM (Exec Edge)
Jul-07-26 09:22AM	How To Target A 10% Yield While Catching The BSX Stock Knife? (Trefis)
07:10AM	Insulet launches Omnipod 5 in Spain (MedTech Dive)
Jul-02-26 01:38PM	What Could Push BSX Stock Higher From Here? (Trefis)
Jul-01-26 06:02PM	When Multi-Cancer Blood Screens Could Finally Take Off (Barrons.com)
01:33PM	Baird starts Abbott at Outperform, sees product pipeline driving growth (Investing.com)
Jun-30-26 09:57AM	US criminal probe into Abbott infant-formula plant closed (Just Food)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MCCOY JOHN A. JR.	VICE PRESIDENT AND CONTROLLER	Sep 02 '26	Sale	109.54	27	2,958	24,549	Sep 03 06:11 PM
John A. McCoy, Jr.	Officer	Sep 02 '26	Proposed Sale	109.52	27	2,957		Sep 02 05:17 PM
Ford Robert B	CHAIRMAN AND CEO	Aug 25 '26	Option Exercise	54.02	398,832	21,545,946	705,293	Aug 27 05:09 PM
Ford Robert B	CHAIRMAN AND CEO	Aug 25 '26	Sale	115.85	398,832	46,204,798	306,461	Aug 27 05:09 PM
Robert B. Ford	Officer	Aug 25 '26	Proposed Sale	115.85	398,832	46,204,386		Aug 25 06:05 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Aug 11 '26	Sale	109.83	5,850	642,506	70,724	Aug 13 05:14 PM
Louis H. Morrone	Officer	Aug 11 '26	Proposed Sale	109.83	5,850	642,506		Aug 11 06:22 PM
Stratton John G	Director	May 07 '26	Buy	86.82	2,000	173,640	23,319	Jun 18 05:08 PM
Robert J. Alpern	Retired Director	May 15 '26	Proposed Sale	85.25	7,587	646,791		May 15 04:15 PM
STARKS DANIEL J	Director	Apr 27 '26	Buy	92.65	10,000	926,537	6,751,103	Apr 28 07:37 PM
Robert J. Alpern	Retired Director	Apr 27 '26	Proposed Sale	92.55	29,211	2,703,457		Apr 27 06:34 PM
Boudreau Philip P	EVP AND CFO	Apr 23 '26	Buy	91.50	2,200	201,300	2,200	Apr 27 05:34 PM
Shroff Eric	Senior Vice President	Mar 02 '26	Sale	115.58	709	81,946	39,164	Mar 03 08:20 PM
Salvadori Daniel Gesua Sive	EVP AND GROUP PRESIDENT	Mar 02 '26	Sale	115.58	885	102,288	146,377	Mar 03 08:10 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Mar 02 '26	Sale	115.58	1,144	132,224	76,843	Mar 03 08:06 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Mar 02 '26	Sale	115.58	613	70,851	104,291	Mar 03 08:00 PM
MCCOY JOHN A. JR.	VICE PRESIDENT AND CONTROLLER	Mar 02 '26	Sale	115.58	585	67,614	24,628	Mar 03 07:55 PM
Cushman Elizabeth C.	EVP, GC AND SECRETARY	Mar 02 '26	Sale	115.58	263	30,398	38,573	Mar 03 07:39 PM
Eric Shroff	Officer	Mar 02 '26	Proposed Sale	115.58	709	81,946		Mar 02 08:36 PM
Daniel Gesua Sive Salvadori	Officer	Mar 02 '26	Proposed Sale	115.58	885	102,288		Mar 02 08:23 PM
Louis H. Morrone	Officer	Mar 02 '26	Proposed Sale	115.58	1,144	132,223		Mar 02 08:16 PM
Mary K. Moreland	Officer	Mar 02 '26	Proposed Sale	115.58	613	70,850		Mar 02 08:05 PM
John A. McCoy, Jr.	Officer	Mar 02 '26	Proposed Sale	115.58	585	67,614		Mar 02 07:59 PM
Elizabeth C. Cushman	Officer	Mar 02 '26	Proposed Sale	115.58	263	30,397		Mar 02 07:53 PM
STARKS DANIEL J	Director	Feb 04 '26	Buy	108.73	10,000	1,087,331	6,738,817	Feb 06 08:04 AM
Ford Robert B	CHAIRMAN AND CEO	Jan 23 '26	Buy	107.13	18,800	2,013,967	216,203	Jan 26 08:02 AM
Shroff Eric	Senior Vice President	Nov 25 '25	Sale	128.02	1,586	203,043	30,384	Nov 25 04:17 PM
Eric Shroff	Officer	Nov 25 '25	Proposed Sale	128.02	1,586	203,042		Nov 25 04:08 PM

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Executive Chairman & CEOMr. Robert B. Ford

CFO & Executive VP of FinanceMr. Philip P. Boudreau

Executive VP and Group President of Established Pharmaceuticals & Nutritional ProductsMr. Daniel Gesua Sive Salvadori

Executive Vice President of Diabetes CareMr. Christopher J. Scoggins

Executive VP & Group President of Medical DevicesMs. Lisa D. Earnhardt

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABT

Abbott Laboratories

Upgrade your Finviz experience